by Warren Lewis | Jan 9, 2025 | News
Queen Mary BioEnterprises Innovation Centre: A New Hub for Life Sciences Startups in Whitechapel Queen Mary BioEnterprises Innovation Centre has teamed up with Lateral and HIG to run its new incubator hub. The 37,000 sq. ft. facility will be part of a larger...
by admin | Aug 7, 2019 | News
hVIVO successfully completes RSV challenge study in Older Adults London, UK – 6 August 2019: hVIVO plc (AIM: HVO), an industry leading clinical development services business pioneering human disease models based upon viral challenge, announces the successful...
by admin | Sep 20, 2018 | News
Queen Mary joins London cancer research powerhouse The city of London will be transformed into a world leading hub for cancer biotherapeutics research and treatment, with a new £14 million investment from Cancer Research UK, announced today. The new Cancer Research...
by admin | Sep 5, 2016 | News
hVIVO Landmark Asthma Stratification Initiative Underway hVIVO plc (AIM: HVO), the pioneer of human disease models, is delighted to announce that the Company’s landmark asthma stratification initiative is now underway, with the first volunteer inoculated with human...
by admin | Nov 21, 2015 | News
Retroscreen Virology Changes its Name to hVIVO Retroscreen Virology is proud to announce corporate name change to hVIVO to reflect pioneering efforts in human disease models. Revolutionising drug development through human studies Retroscreen Virology, a leading life...
